Does the Osteoporosis Dose of Denosumab Really Cause Clinically Significant Hypocalcaemia in CKD 4 and 5
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2014, Vol 4, Issue 2
Abstract
Denosumab is a potent novel antiresorptive agent for treatment of osteoporosis with unique mechanism of action . It is a fully human monoclonal antibody to the receptor activator of nuclear factor-κB ligand (RANKL) that blocks its binding to RANK, inhibiting the development and activity of osteoclasts, decreasing bone resorption, and increasing bone density. Initially denosumab appeared particularly promising for patients with advanced stages of renal failure but over the past two years several publications questioned that, reporting adverse effects and especially severe hypocalcaemia. Aim of the Study: to investigate further the effect of the osteoporosis dose of denosumab on serum calcium levels in patients with CKD 4 and CKD 5. Methods: This retrospective outpatient study included 17 females with CKD 4 and 5 who received a single or a multiple (at 6 months intervals) 60-mg subcutaneous dose of denosumab. Adjusted serum Calcium was measured prior to the dose and at various points of time after that. Results: Only two of the subjects developed clinically significant hypocalcaemia. Both of them were clearly inadequately supplemented with calcium and vitamin D. Conclusion: The results from the current study along with a critical analysis of the previous publications reveal that the vast majority of the previous reports were based on inadequately supplemented with calcium and vitamin D patients and that severe hypocalcaemia is unlikely in appropriately supplemented subjects, especially in the CKD 4 subgroup. However, due to the scarcity of data further research is warranted, especially in the CKD 5 subgroup. In the mean time more cautious approach rather than a blanket ban on denosumab appears to be the most appropriate policy in these two populations.
Authors and Affiliations
Petko Ivanov
Keywords
Related Articles
- EP ID EP348497
- DOI 10.9734/BJMMR/2014/6300
- Views 58
- Downloads 0
The Role of Indirect Immunofluorescence Methods in the Detection of Autoimmune Antibodies in Thyroid Disease
Aims: In this study, we evaluated the prevalence of antithyroglobulin antibodies (anti-Tg Ab) and antipyroxidase antibodies (anti-TPO Ab) in thyroid disease and investigated the role of indirect immunofluorescence method...
Haematological and Kidney Function Indices of Piliostigma thonningii Leaf Extract Administration Following Pefloxacin Induced Toxicity in Wistar Rats
Aims: The study investigated haematological and kidney function indices of Wistar rats administered Piliostigma thonningii ethanol leaf extract after being induced with therapeutic doses of pefloxacin (400 mg/5 mL). Plac...
Rare Case of Multiple Compound Odontomas with Dens Invaginatus Associated with Impacted Primary and Unerupted Permanent Maxillary Central Incisor – A Case Report
Aims: An Odontoma is usually found in the surrounding area of the unerupted permanent tooth bud and rarely adjacent to the primary central incisor. Histopathological examination of the Odontoma revealed presence of surfa...
A Different from of Sternal Reconstruction: A Case Study
Currently, almost all sternum defects, with or without tissue loss, can be repaired through various kinds of surgical procedures and grafts. A patient diagnosed with multiple myeloma one and a half years earlier experien...
ABO and Rh Blood Group System and Periodontal Disease - A Prevalence Study
Background: Varied literature is documented exploring the relationship between ABO blood group and prevalence of oral and dental diseases. The aim of this study was to investigate the correlation of periodontal disease w...